Owonikoko, Taofeek K, Kyriakos P Papadopoulos, Melissa L Johnson, and Et al. “Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients With Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Final Efficacy and Safety Data”. SKIN The Journal of Cutaneous Medicine 20 (December 17, 2018): S78. Accessed December 2, 2020. https://jofskin.org/index.php/skin/article/view/474.